Penumbra, Inc. (NYSE:PEN) Shares Sold by Prudential Financial Inc.

Prudential Financial Inc. cut its position in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 21.

3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,763 shares of the company’s stock after selling 478 shares during the quarter. Prudential Financial Inc.



’s holdings in Penumbra were worth $419,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.

a. increased its holdings in shares of Penumbra by 57.4% in the 4th quarter.

UMB Bank n.a. now owns 192 shares of the company’s stock valued at $46,000 after purchasing an additional 70 shares during the period.

Mather Group LLC. lifted its holdings in Penumbra by 208.0% in the 4th quarter.

Mather Group LLC. now owns 308 shares of the company’s stock worth $73,000 after purchasing an additional 208 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Penumbra by 25.

0% during the 4th quarter. Jones Financial Companies Lllp now owns 375 shares of the company’s stock worth $89,000 after buying an additional 75 shares during the period. GAMMA Investing LLC boosted its stake in Penumbra by 160.

8% during the 4th quarter. GAMMA Investing LLC now owns 446 shares of the company’s stock valued at $106,000 after purchasing an additional 275 shares during the period. Finally, Blue Trust Inc.

grew its stake in shares of Penumbra by 43.4% in the fourth quarter. Blue Trust Inc.

now owns 730 shares of the company’s stock worth $173,000 after acquiring an additional 221 shares during the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

Insider Buying and SellingIn related news, CFO Maggie Yuen sold 2,000 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $286.00, for a total value of $572,000.

00. Following the completion of the transaction, the chief financial officer now owns 15,243 shares of the company’s stock, valued at $4,359,498. The trade was a 11.

60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction that occurred on Monday, March 3rd.

The stock was sold at an average price of $287.43, for a total transaction of $172,458.00.

Following the sale, the executive vice president now directly owns 66,539 shares of the company’s stock, valued at approximately $19,125,304.77. This trade represents a 0.

89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 111,236 shares of company stock valued at $31,222,390.

Company insiders own 5.00% of the company’s stock. Penumbra Stock PerformanceShares of NYSE PEN opened at $275.

71 on Thursday. Penumbra, Inc. has a 52 week low of $148.

00 and a 52 week high of $310.00. The stock has a market capitalization of $10.

62 billion, a PE ratio of 810.91, a price-to-earnings-growth ratio of 2.83 and a beta of 0.

56. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.

25 and a current ratio of 6.01. The stock has a 50 day moving average price of $274.

05 and a 200 day moving average price of $247.67. Penumbra (NYSE:PEN – Get Free Report) last issued its earnings results on Tuesday, February 18th.

The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.88 by $0.

09. Penumbra had a net margin of 1.17% and a return on equity of 9.

74%. The company had revenue of $315.52 million for the quarter, compared to analysts’ expectations of $311.

63 million. Analysts predict that Penumbra, Inc. will post 3.

67 earnings per share for the current fiscal year. Analyst Upgrades and DowngradesA number of brokerages have commented on PEN. JPMorgan Chase & Co.

raised their price objective on Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th.

Wells Fargo & Company upped their target price on shares of Penumbra from $275.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th.

Robert W. Baird raised their target price on shares of Penumbra from $305.00 to $328.

00 and gave the company an “outperform” rating in a research note on Wednesday, February 19th. Royal Bank of Canada increased their target price on Penumbra from $285.00 to $313.

00 and gave the company an “outperform” rating in a research note on Wednesday, February 19th. Finally, Truist Financial boosted their price target on shares of Penumbra from $285.00 to $325.

00 and gave the company a “buy” rating in a report on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.

com, Penumbra presently has an average rating of “Moderate Buy” and a consensus target price of $294.47.Get Our Latest Analysis on PenumbraPenumbra Company Profile (Free Report)Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.Further ReadingFive stocks we like better than PenumbraWhy Are These Companies Considered Blue Chips?Quantum Computing: The $6.5 Billion Opportunity You Can’t IgnoreWhat is the Australian Securities Exchange (ASX) Are Tariffs Threatening Disney’s Comeback Story?Investing in the High PE Growth Stocks Is Alphabet a Generational Buying Opportunity at These Levels?Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Penumbra, Inc. (NYSE:PEN – Free Report)..